Numerical Study of Hyper‐Thermic Laser Lipolysis With 1,064 nm Nd:YAG Laser in Human Subjects

2019 ◽  
Vol 51 (10) ◽  
pp. 897-909 ◽  
Author(s):  
Matija Milanic ◽  
Blaz Tasic Muc ◽  
Nejc Lukac ◽  
Matjaz Lukac
2005 ◽  
Vol 36 (1) ◽  
pp. 43-46 ◽  
Author(s):  
Kota Ichikawa ◽  
Muneo Miyasaka ◽  
Rica Tanaka ◽  
Ryuzaburo Tanino ◽  
Kana Mizukami ◽  
...  

2012 ◽  
Vol 58 (2) ◽  
pp. 21101
Author(s):  
J. Chen ◽  
B. Han ◽  
B.-B. Li ◽  
Z.-H. Shen ◽  
J. Lu ◽  
...  
Keyword(s):  

2009 ◽  
Vol 48 (12) ◽  
pp. 1353-1359 ◽  
Author(s):  
Yong Kwan Rho ◽  
Beom Joon Kim ◽  
Myeung Nam Kim ◽  
Kweon Soo Kang ◽  
Hee Jin Han
Keyword(s):  

2007 ◽  
Vol 27 (3) ◽  
pp. 263-268 ◽  
Author(s):  
S MORDON ◽  
A EYMARDMAURIN ◽  
B WASSMER ◽  
J RINGOT

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Carlo Fornaini ◽  
Elisabetta Merigo ◽  
Igor Cernavin ◽  
Gonzalo Lòpez de Castro ◽  
Paolo Vescovi

The aim of this clinical study was to describe the possibility of using the Nd:YAG laser device utilized in the dental offices to weld metals intraorally. The authors, before applying this technique “in vivo” on human subjects, tested the “in vitro” metal welding efficacy of dental Nd:YAG device firstly by interferometry, SEM, and EDS and subsequently by thermal camera and thermocouples in order to record temperature changes during the welding process on bovine jaws. Four implants were inserted in the edentulous maxillary arch of a 67 years old male patient. Immediately after that, a bar previously made by the dental technician was intraorally welded to the abutments by Nd:YAG laser (Fidelis Plus III, Fotona, Slovenia) with these parameters: 9.90 mJ, 1 Hz, 15 msec, 0.6 mm spot. Then the prosthesis was connected to the bar with four OT Caps. This clinical study, even if preliminary, suggests that laser welding technique may be intraorally used without side effects.


2006 ◽  
Vol 32 (2) ◽  
pp. 241-248 ◽  
Author(s):  
KAREN H. KIM ◽  
ROY G. GERONEMUS
Keyword(s):  

2019 ◽  
Vol 133 (22) ◽  
pp. 2283-2299
Author(s):  
Apabrita Ayan Das ◽  
Devasmita Chakravarty ◽  
Debmalya Bhunia ◽  
Surajit Ghosh ◽  
Prakash C. Mandal ◽  
...  

Abstract The role of inflammation in all phases of atherosclerotic process is well established and soluble TREM-like transcript 1 (sTLT1) is reported to be associated with chronic inflammation. Yet, no information is available about the involvement of sTLT1 in atherosclerotic cardiovascular disease. Present study was undertaken to determine the pathophysiological significance of sTLT1 in atherosclerosis by employing an observational study on human subjects (n=117) followed by experiments in human macrophages and atherosclerotic apolipoprotein E (apoE)−/− mice. Plasma level of sTLT1 was found to be significantly (P<0.05) higher in clinical (2342 ± 184 pg/ml) and subclinical cases (1773 ± 118 pg/ml) than healthy controls (461 ± 57 pg/ml). Moreover, statistical analyses further indicated that sTLT1 was not only associated with common risk factors for Coronary Artery Disease (CAD) in both clinical and subclinical groups but also strongly correlated with disease severity. Ex vivo studies on macrophages showed that sTLT1 interacts with Fcɣ receptor I (FcɣRI) to activate spleen tyrosine kinase (SYK)-mediated downstream MAP kinase signalling cascade to activate nuclear factor-κ B (NF-kB). Activation of NF-kB induces secretion of tumour necrosis factor-α (TNF-α) from macrophage cells that plays pivotal role in governing the persistence of chronic inflammation. Atherosclerotic apoE−/− mice also showed high levels of sTLT1 and TNF-α in nearly occluded aortic stage indicating the contribution of sTLT1 in inflammation. Our results clearly demonstrate that sTLT1 is clinically related to the risk factors of CAD. We also showed that binding of sTLT1 with macrophage membrane receptor, FcɣR1 initiates inflammatory signals in macrophages suggesting its critical role in thrombus development and atherosclerosis.


Sign in / Sign up

Export Citation Format

Share Document